Challenging the standard of care in advanced melanoma: focus on pembrolizumab

Challenging the standard of care in advanced melanoma: focus on pembrolizumab

Raghad M Abdul-Karim,1 C Lance Cowey2–4 1Baylor Sammons Cancer Center, 2Melanoma and Genitourinary Oncology Program, Baylor University Medical Center, Sammons Cancer Center Texas Oncology,3Baylor Skin Malignancy Research and Treatment Center, Baylor University Medical Center, 4Developmenta...

Full description

Bibliographic Details
Main Authors: Abdul-Karim RM, Cowey CL
Format: Article
Language:English
Published: Dove Medical Press 2017-09-01
Series:Cancer Management and Research
Subjects:
Pembrolizumab
Keytruda
MK-3475
Melanoma
Immune Checkpoint Inhibitor
PD-1 Inhibitor
Adjuvant Therapy
Combination Therapies
Online Access:https://www.dovepress.com/challenging-the-standard-of-care-in-advanced-melanoma-focus-on-pembrol-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/challenging-the-standard-of-care-in-advanced-melanoma-focus-on-pembrol-peer-reviewed-article-CMAR

Similar Items